Info

🌱來自: snippets

GC

Gastric cancer, (P/D) adenocrcinoma, bormann type III pT4bN3bM1 (AJCC 7th), pancreatic invasion, omentum mets, LN less curvature (7/22), greater curvature (8/28) s/p palliative subtotal gastrectomy on 2017/00/00, LVI+, perineural invasion

  • Initial presentation
  • Treatment plan: palliative chemotherapy
  • Follow up parameter: abdominal CT scan and CEA/CA199 if elevated
  • 2017/00/00: the purpose of palliative chemotherapy is to control disease and prolong life and maintain quality of life but not cure. Explain high risk for local recurrence and distant mets to liver or peritoneum and cause ascites, bowel obstruction and etc
  • 2017/00/00 explain palliative chemotherapy treatment option, such as 5-FU based, capecitabine based, TS-1, taxane based, irinotecan based, and etc, 1st line treatment suggested XELOX, modified ECF, TS-1, or weekly HDFL/LV @ Start palliatve chemotherapy today, explain treatment options @ Vascular assessment, nutritional assessment, dental check, pharmacist education before chemotherapy. @ pending for HER2-neur IHC stain

Siblings